TITLE

Actualidades en la susceptibilidad antimicrobiana de microorganismos causales de infecciones respiratorias en pacientes ambulatorios

AUTHOR(S)
Angulo, Gustavo Barriga; Escorza, Carlos Arumir; Mercado González, Nina Fabiola
PUB. DATE
January 2008
SOURCE
Revista Mexicana de Patologia Clinica;ene-mar2008, Vol. 55 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To evaluate the in vitro activity of twelve antimicrobial agents against 600 bacterial strains isolated from the same number of outpatients with respiratory infections. Material and methods: A prospective study was conducted in the bacterial strains isolated from outpatients with acute respiratory infections from La Raza Medical Center (IMSS) using a microdilution method and determine minimal inhibitory concentrations 50 and 90. Results: Clarithromycin was the most active of the twelve antimicrobials evaluated, with the lowest minimal inhibitory concentrations and the lowest resistance, most of the strains show resistance to fluoroquinolones; we do not find Streptococcus pyogenes strains resistant to Clarithromycin. Streptococcus pneumoniae was the most frequent etiological agent isolated and with the highest minimal inhibitory concentration as and percents of resistance. Conclusions: Clarithromycin was the antimicrobial of first election for the treatment of active respiratory infections in outpatients.
ACCESSION #
35705519

 

Related Articles

  • Antimicrobial susceptibility of select respiratory tract pathogens in Dakar, Senegal. Ndiaye, Aissatou Gueye; Boye, Cheikh Saadbou; Hounkponou, Edwige; Gueye, Fatou Bintou; Badiane, Aida // Journal of Infection in Developing Countries;2009, Vol. 3 Issue 9, p660 

    Background : Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pyogenes, and Streptococcus pneumoniae are the most common causative agents of respiratory tract infections (RTIs). The increase in resistance to current antibacterial agents highlights the need to monitor the resistance...

  • Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Albrich, Werner C.; Monnet, Dominique L.; Harbarth, Stephan // Emerging Infectious Diseases;Mar2004, Vol. 10 Issue 3, p514 

    We correlated outpatient antibiotic use with prevalence of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP), macrolide-resistant S. pneumoniae (MRSP), and macrolide-resistant S. pyogenes (MRGAS) in 20 countries. Total antibiotic use was correlated with PNSP (r= 0.75; p < 0.001), as was...

  • Antimicrobial Use and the Emergence of Antimicrobial Resistance with Streptococcus pneumoniae in the United States. Doem, Gary V. // Clinical Infectious Diseases;9/15/2001 Supplement 3, Vol. 33, pS187 

    The rapid emergence of resistance to antimicrobial agents by Streptococcus pneumoniae in the United States has been influenced by various factors, including the clonal nature of most resistant strains and the fact that organisms with a multiresistant phenotype have become stably endemic. The...

  • Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae. Diekema, Daniel J.; Brueggemann, Angela B.; Doern, Gary V. // Emerging Infectious Diseases;Sep/Oct2000, Vol. 6 Issue 5, p552 

    Resistance of Streptococcus pneumoniae to antimicrobial drugs is increasing. To investigate the relationship between antimicrobial use and susceptibility of S. pneurnoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of...

  • Macrolide-Resistant Streptococcus pyogenes in the United States, 2002-2003. Richter, Sandra S.; Heilmann, Kristopher P.; Beekmann, Susan E.; Miller, Norma J.; Miller, Ashley L.; Rice, Cassie L.; Doern, Christopher D.; Reid, Sean D.; Doern, Gary V. // Clinical Infectious Diseases;9/1/2005, Vol. 41 Issue 5, p599 

    Background. Increased levels of macrolide-resistant Streptococcus pyogenes in focal regions of the United States have been reported. The purpose of this study was to determine the antimicrobial susceptibility of a large collection of S. pyogenes isolates from throughout the United States and to...

  • The Antimicrobial in Vitro Effects of Different Concentrations of Some Plant Extracts Including Tamarisk, March, Acetone and Mango Kernel. Shabani, Ziba; Sayadi, Ahmad // Journal of Applied Pharmaceutical Science;May2014, Vol. 4 Issue 5, p75 

    The present study was aimed to assess the plants antimicrobial effects such as Tamarisk, March, acetone and mango kernel. The aqueous and ethanol extract of the plants and also its smoke was prepared in concentrations of 50 and 25 mg/mL. The bacteria Staphylococcus aureus, Streptococcus...

  • Declines in Outpatient Antimicrobial Use in Canada (1995–2010). Finley, Rita; Glass-Kaastra, Shiona K.; Hutchinson, Jim; Patrick, David M.; Weiss, Karl; Conly, John // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: With rising reports of antimicrobial resistance in outpatient communities, surveillance of antimicrobial use is imperative for supporting stewardship programs. The primary objective of this article is to assess the levels of antimicrobial use in Canada over time. Methods: Canadian...

  • Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Riedel, S.; Beekmann, S. E.; Heilmann, K. P.; Richter, S. S.; Garcia-de-Lomas, J.; Ferech, M.; Goosens, H.; Doern, G. V. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2007, Vol. 26 Issue 7, p485 

    The study presented here determined the relationship between antimicrobial resistance in Streptococcus pneumoniae and the use of antimicrobial agents in 15 different European countries. Pneumococcal isolates ( n = 1974) recovered from patients with community-acquired respiratory tract infections...

  • Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. Doern, Gary V.; Brueggemann, Angela B.; Doern, G V; Brueggemann, A B; Huynh, H; Wingert, E // Emerging Infectious Diseases;Nov/Dec99, Vol. 5 Issue 6, p757 

    From November 1997 to April 1998, 1,601 clinical isolates of Streptococcus pneumoniae were obtained from 34 U.S. medical centers. The overall rate of strains showing resistance to penicillin was 29. 5%, with 17.4% having intermediate resistance. Multidrug resistance, defined as lack of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics